OVID - RBC bullish on OVID's 2020 catalysts November, 29 2019 07:27 AM Ovid Therapeutics Inc. RBC Capital analyst Brian Abrahams sees a favorable risk-reward for Ovid Therapeutics (NASDAQ:OVID) heading into next year.More news on: Ovid Therapeutics Inc., Healthcare stocks news, Stocks on the move, Read more ...